Heron Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RUBRIC CAPITAL MANAGEMENT LP | 11/14/2025 | 29.10 M | $36.67 M | 8.94% | 18.89% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2025 | 10.24 M | $12.90 M | 30.40% | 6.65% |
| BLACKROCK, INC. | 11/12/2025 | 9.99 M | $12.58 M | -1.13% | 6.48% |
| CLEARLINE CAPITAL LP | 11/14/2025 | 9.71 M | $12.24 M | 1,033.10% | 6.31% |
| VELAN CAPITAL INVESTMENT MANAGEMENT LP | 11/14/2025 | 8.75 M | $11.03 M | 25.28% | 5.68% |
| VANGUARD GROUP INC | 11/07/2025 | 8.46 M | $10.66 M | -0.14% | 5.49% |
| PALISADE CAPITAL MANAGEMENT, LP | 11/14/2025 | 7.33 M | $9.23 M | 44.05% | 4.76% |
| TEJARA CAPITAL LTD | 11/04/2025 | 4.59 M | $5.78 M | 1.60% | 2.98% |
| BAKER BROS. ADVISORS LP | 11/14/2025 | 4.25 M | $5.36 M | 100.00% | 2.76% |
| STATE STREET CORP | 11/14/2025 | 3.65 M | $4.60 M | 5.47% | 2.37% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 3.64 M | $4.59 M | 2.14% | 2.37% |
| TANG CAPITAL MANAGEMENT LLC | 11/14/2025 | 3.45 M | $4.35 M | 61.56% | 2.24% |
| JW ASSET MANAGEMENT, LLC | 11/07/2025 | 3.29 M | $4.15 M | 40.85% | 2.14% |
| D. E. SHAW & CO., INC. | 11/14/2025 | 3.09 M | $3.89 M | -3.49% | 2.01% |
| UBS GROUP AG | 11/13/2025 | 2.93 M | $3.70 M | -7.88% | 1.91% |
| CONGRESS PARK CAPITAL LLC | 10/08/2025 | 2.89 M | $3.64 M | 27.42% | 1.88% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 2.85 M | $3.60 M | 6.16% | 1.85% |
| CITADEL ADVISORS LLC | 11/14/2025 | 2.71 M | $3.41 M | 21.90% | 1.76% |
| NEW YORK STATE COMMON RETIREMENT FUND | 11/03/2025 | 2.58 M | $3.25 M | 46.40% | 1.67% |
| CITIGROUP INC | 11/10/2025 | 2.48 M | $3.12 M | 4,666.86% | 1.61% |
| MORGAN STANLEY | 11/14/2025 | 2.47 M | $3.11 M | -10.63% | 1.60% |
| CAPTION MANAGEMENT, LLC | 11/14/2025 | 2.00 M | $2.52 M | 100.00% | 1.30% |
| AQR CAPITAL MANAGEMENT LLC | 11/14/2025 | 1.94 M | $2.44 M | 3,036.39% | 1.26% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 1.32 M | $1.67 M | 26.98% | 0.86% |
| MARSHALL WACE, LLP | 11/13/2025 | 1.31 M | $1.65 M | -54.77% | 0.85% |
| JPMORGAN CHASE & CO | 11/26/2025 | 1.29 M | $1.63 M | 35.61% | 0.84% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 1.28 M | $1.61 M | 7.67% | 0.83% |
| NORTHERN TRUST CORP | 11/14/2025 | 1.16 M | $1.46 M | 0.43% | 0.75% |
| MONACO ASSET MANAGEMENT SAM | 11/10/2025 | 1.00 M | $1.26 M | -7.18% | 0.65% |
| STONEPINE CAPITAL MANAGEMENT, LLC | 11/13/2025 | 850.10 K | $1.07 M | 29.32% | 0.55% |
| CM MANAGEMENT, LLC | 11/13/2025 | 750.00 K | $945.00 K | 25.00% | 0.49% |
| CAPTION MANAGEMENT, LLC | 11/14/2025 | 734.30 K | $925.21 K | 100.00% | 0.48% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 732.07 K | $922.41 K | -31.92% | 0.48% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2025 | 700.00 K | $882.00 K | 0.00% | 0.45% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2025 | 692.28 K | $872.27 K | -26.40% | 0.45% |
| ORCHARD CAPITAL MANAGEMENT, LLC | 11/12/2025 | 677.29 K | $853.39 K | 2.63% | 0.44% |
| RICHMOND BROTHERS, INC. | 11/10/2025 | 572.12 K | $720.87 K | 3.18% | 0.37% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2025 | 525.77 K | $662.48 K | 6.63% | 0.34% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 11/14/2025 | 475.75 K | $599.45 K | 0.00% | 0.31% |
| PALE FIRE CAPITAL SE | 11/13/2025 | 471.19 K | $593.70 K | 100.00% | 0.31% |
| BANK OF NEW YORK MELLON CORP | 11/03/2025 | 412.47 K | $519.72 K | 2.58% | 0.27% |
| BNP PARIBAS ARBITRAGE, SNC | 11/13/2025 | 378.59 K | $477.02 K | 23.79% | 0.25% |
| NUVEEN, LLC | 11/12/2025 | 347.07 K | $437.30 K | 0.00% | 0.23% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 328.97 K | $414.50 K | -23.86% | 0.21% |
| BARCLAYS PLC | 11/12/2025 | 279.36 K | $351.99 K | -13.09% | 0.18% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 248.50 K | $313.11 K | -49.53% | 0.16% |
| CYNDEO WEALTH PARTNERS, LLC | 10/10/2025 | 248.09 K | $312.59 K | 0.00% | 0.16% |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 10/20/2025 | 246.41 K | $310.48 K | -7.41% | 0.16% |
| INVESCO LTD. | 11/13/2025 | 231.40 K | $291.56 K | 33.69% | 0.15% |
| RHUMBLINE ADVISERS | 11/06/2025 | 224.65 K | $283.05 K | 1.00% | 0.15% |
Heron Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 259 institutional investors and hedge funds held shares of Heron Therapeutics, Inc.. The most heavily invested institutionals were:
Rubric Capital Management LP: 29.1 M
ADAGE CAPITAL PARTNERS GP, L.L.C.: 10.24 M
BlackRock, Inc.: 9.99 M
Clearline Capital LP: 9.71 M
Velan Capital Investment Management LP: 8.75 M
VANGUARD GROUP INC: 8.46 M
99.12% of Heron Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 174.61 M shares in the last 24 months. This purchase volume represents approximately $230.48 M in transactions.